What is Relief TMS?
Relief TMS is a specialized provider of Transcranial Magnetic Stimulation (TMS) therapy, offering a non-invasive, FDA-approved treatment for conditions such as depression and OCD. Leveraging advanced BrainsWay Deep TMS technology, the company targets individuals who have not found adequate relief through conventional pharmaceutical treatments. Relief TMS focuses on delivering personalized outpatient care plans designed to adapt to patient needs, with many clients reporting improvements within a 4-6 week period. Their commitment lies in enhancing patient mental well-being while mitigating the systemic side effects often associated with antidepressant medications.
How much funding has Relief TMS raised?
Relief TMS has raised a total of $14K across 1 funding round:
Debt
$14K
Debt (2021): $14K with participation from PPP
Key Investors in Relief TMS
PPP
Public-Private Partnership
What's next for Relief TMS?
With the recent influx of moderate growth capital, Relief TMS is strategically positioned to enhance its service offerings and expand its operational footprint. The company's focus on non-invasive mental health treatments aligns with a growing market demand for alternative therapeutic solutions. Future initiatives are likely to involve scaling its TMS therapy services, potentially through new clinic openings or strategic partnerships, to reach a broader patient demographic. Continued investment in technology and patient care protocols will be crucial for sustaining its growth trajectory and solidifying its market position in the competitive mental wellness landscape.
See full Relief TMS company page
